Stock KGET CALIPHARMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

CaliPharms, Inc. Stock Other OTC

Equities

KGET

US4984561021

Pharmaceuticals

Financials (USD)

Sales 2012 - Sales 2013 - Capitalization 8.23M
Net income 2012 - Net income 2013 - EV / Sales 2012 * -
Net Debt 2012 617K Net Debt 2013 667K EV / Sales 2013 -
P/E ratio 2012 *
-
P/E ratio 2013
-0.51 x
Employees -
Yield 2012 *
-
Yield 2013
-
Free-Float 100%
More Fundamentals * Assessed data

Chart CaliPharms, Inc.

Dynamic Chart

Latest news about CaliPharms, Inc.

CaliPharms, Inc. Launches a New CBD Muscle & Joint Relief Roll On Gel CI
Joe Pavlik Joins the Advisory Board of CaliPharms, Inc CI
Calipharms Announces Beverage Master Distributor Agreement with One Elite Sports CI
CaliPharms Mulls Acquisitions CI
Bayport International Holdings, Inc. Engages CaliPharms, Inc. to Expand CBD Product Offering for Weedwiser e-commerce Platform CI
CaliPharms Mulls Acquisitions CI
CaliPharms Enters Acquisition Discussions With United Cannabis CI
CaliPharms, Inc. completed the acquisition of 51% stake in Pacific Cannabis Growers, Inc. CI
CaliPharms, Inc. signed a non-binding term sheet to acquire 51% stake in Pacific Cannabis Growers, Inc. CI
Kleangas Energy Technologies, Inc. completed the acquisition of 51% stake in Country Junction Farms. CI
Kleangas Energy Technologies, Inc. signed a terms sheet to acquire Country Junction Farms for $3.4 million. CI
Kleangas Energy Seeks Acquisitions CI
Kleangas Energy Technologies, Inc cancelled the acquisition of Company, Inc. (“CI”) from Jerry Hansen, Tracy Johnson and The PI Foundation. CI
Kleangas Energy Technologies, Inc. Ships 200 Metric Tons of Wood Pellets to Korea CI
Kleangas Energy Technologies, Inc entered into stock purchase agreement to acquire Company, Inc from Jerry Hansen, Tracy Johnson and The PI Foundation for $7.3 million. CI
More news

Press releases CaliPharms, Inc.

CaliPharms Debuts New CBD Muscle & Joint Relief Product at Marijuana Business Conference in Las Vegas GL
CaliPharms has Embarked on the Research and Development of its Initial Series of Naturally Derived CBD (Cannabidiol) Products GL
Celebrity Fitness Expert & Formulator Joe Pavlik Joins the CaliPharms Advisory Board GL
CaliPharms Enters Discussions With THC Beverage Company and CBD Producer GL
CaliPharms And Beverage Master Distributor Sign LOI GL
More press releases

Company Profile

CaliPharms Inc is a developmental stage acquisition company. The Company is focused on acquiring, merging, and joint venturing with legally permitted fully operational marijuana-cannabis businesses. The Company is seeking acquisitions in medical marijuana-cannabis cultivation. The Company focuses on the medical-grade marijuana-cannabis within the State of California. The Company is also expanding into other sectors that support the legalized marijuana industry.
Sector
Pharmaceuticals
More about the company

Sector Alternative Medicine

1st Jan change Capi.
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+37.37% 6.05B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.69% 4.45B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-12.46% 3.06B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
-0.12% 3.04B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
+0.47% 2.58B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+36.06% 1.79B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+0.84% 1.66B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-10.60% 1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.03% 1.54B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. KGET Stock
  4. KGET Stock